4th Quarter - Report

ALTRIA CLIENT SERVICES LLC for ALTRIA CLIENT SERVICES LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$2,510,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 21, 2021 $2,510,000 Replaced
4th Quarter - Amendment Mar 5, 2021 $2,520,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

HR 1175/S 362 Craft Beverage Modernization and Tax Reform Act of 2019; provisions related to craft beverage tax relief HR 4509/S 2589 To amend the Internal Revenue Code of 1986 to restore the limitation on downward attribution of stock ownership in applying the constructive ownership rules to controlled foreign corporations, and for other purposes; all provisions of the bill

LobbyistCovered position, as disclosed
MICHELLE DIMAROB —
JOHN HOEL —
PHIL PARK —
TODD WALKER —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4509 (116th), H.R. 1175 (116th)

Tobacco TOB

HR 293 Youth Vaping Prevention Act of 2019; all provisions of the bill HR 1498/S 655 SAFE Kids Act; all provisions of the bill HR 1642/S 1965 Combating the Illicit Trade in Tobacco Products Act; all provisions of the bill HR 1854/S 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019; all provisions of the bill HR 2111PROTECT Act; Reducing Youth Use of E-Cigarettes Initiative; all provisions of the bill HR 2339Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020; all provisions of the bill HR 3942/S 1253Preventing Online Sales of E-Cigarettes to Children Act; all provisions of the bill HR 4425Quell Underage Inhaling of Toxic Substances Act of 2019; all provisions of the bill HR 4624 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2019; all provisions of the bill HR 4742Protecting American Lungs Act of 2019; all provisions of the bill HR 5721/S 3223Resources to Prevent Youth Vaping Act; all provisions of the bill HR 5963E-Cigarette Oversight and Accountability Act of 2020; all provisions of the bill HR 7286/S 4524 Quit Because of COVID-19; all provisions of the bill HR 8343Independent Advisory Committee Review of E-Cigarette Applications Act; all provisions of the bill S 616 E-Cigarette Youth Protection Act; all provisions of the bill S 1048 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction; all provisions of the bill S 1832 Smoke-Free Schools Act of 2019; all provisions of the bill S 2517 Tobacco Tax Equity Act of 2019; all provisions of the bill S 2519 Ending New Nicotine Dependencies Act of 2019 (ENND Act); all provisions of the bill S 3174 Reversing the Youth Tobacco Epidemic Act of 2020; all provisions of the bill ANPRMS for Docket Nos. FDA-2017-N-6189, FDA-2017-N-6565, and FDA-2017-N-6107 Proposed Rule regarding Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Discussions related to tobacco harm reduction Discussions in support of the regulation of products containing synthetic nicotine

LobbyistCovered position, as disclosed
ANGELA ARBOLEDA —
MICHELLE DIMAROB —
CYNTHIA HAYDEN —
JOHN HOEL —
JENNIFER A KANE —
JOHN MASON —
PHIL PARK —
TODD WALKER —

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA)

Bills named: H.R. 1854 (116th), H.R. 4742 (116th), H.R. 2111 (116th), H.R. 4425 (116th), H.R. 3942 (116th), H.R. 5963 (116th), H.R. 7286 (116th), H.R. 2339 (116th), H.R. 293 (116th), H.R. 1642 (116th), H.R. 1498 (116th), H.R. 8343 (116th), H.R. 4624 (116th), H.R. 5721 (116th)

Government Issues GOV

FDA Cannabidiol Enforcement Policy: Draft Guidance for Industry

LobbyistCovered position, as disclosed
MICHELLE DIMAROB —
PHIL PARK —
TODD WALKER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); White House Office; Health & Human Services, Dept of (HHS)

Affiliated organisations

OrganisationLocation
ALTRIA SUMMIT LLC Richmond, VA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.